The use of proton relaxation enhancers in magnetic resonance imaging.
D000230:Adenocarcinoma / Q000175:diagnosis; D000818:Animals; D001254:Astrocytoma / Q000175:diagnosis; D001932:Brain Neoplasms / Q000175:diagnosis; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis; D002528:Cerebellar Neoplasms / Q000175:diagnosis / Q000556:secondary; D002544:Cerebral Infarction / Q000175:diagnosis; D003287:Contrast Media; D004492:Edetic Acid; D005682:Gadolinium; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000556:secondary; D009682:Magnetic Resonance Spectroscopy; D009942:Organometallic Compounds; D004369:Pentetic Acid; D011817:Rabbits; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis
D003287:Contrast Media; D009942:Organometallic Compounds; C041365:gadolinium EDTA; D004369:Pentetic Acid; D004492:Edetic Acid; D005682:Gadolinium